- Home
- RVPH vs SRFM Comparison
RVPH vs SRFM Comparison
Compare RVPH & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SRFM
- Stock Information
- Founded
- RVPH 2006
- SRFM 2011
- Country
- RVPH United States
- SRFM United States
- Employees
- RVPH N/A
- SRFM N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- RVPH Health Care
- SRFM Consumer Discretionary
- Exchange
- RVPH Nasdaq
- SRFM Nasdaq
- Market Cap
- RVPH 32.8M
- SRFM 114.6M
- IPO Year
- RVPH N/A
- SRFM 2023
- Fundamental
- Price
- RVPH $0.39
- SRFM $6.11
- Analyst Decision
- RVPH Strong Buy
- SRFM Buy
- Analyst Count
- RVPH 5
- SRFM 4
- Target Price
- RVPH $9.00
- SRFM $5.56
- AVG Volume (30 Days)
- RVPH 3.7M
- SRFM 20.5M
- Earning Date
- RVPH 08-13-2025
- SRFM 08-13-2025
- Dividend Yield
- RVPH N/A
- SRFM N/A
- EPS Growth
- RVPH N/A
- SRFM N/A
- EPS
- RVPH N/A
- SRFM N/A
- Revenue
- RVPH N/A
- SRFM $112,307,000.00
- Revenue This Year
- RVPH N/A
- SRFM N/A
- Revenue Next Year
- RVPH N/A
- SRFM $54.32
- P/E Ratio
- RVPH N/A
- SRFM N/A
- Revenue Growth
- RVPH N/A
- SRFM 31.17
- 52 Week Low
- RVPH $0.30
- SRFM $0.90
- 52 Week High
- RVPH $4.28
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- RVPH 35.22
- SRFM 63.64
- Support Level
- RVPH $0.38
- SRFM $6.18
- Resistance Level
- RVPH $0.45
- SRFM $9.91
- Average True Range (ATR)
- RVPH 0.05
- SRFM 1.45
- MACD
- RVPH 0.01
- SRFM 0.38
- Stochastic Oscillator
- RVPH 17.57
- SRFM 55.97
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.